EUVIMEDEUVIMED entdecken
Crossref

Accelerated MEN2A in homozygous RET carriers in the context of consanguinity

Andreas Machens iD, Henning Dralle

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Andreas Machens und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, D-06097 Hall…. Hauptthemen laut MEDLINE: Multiple Endocrine Neoplasia Type 2a, Pheochromocytoma, Thyroid Neoplasms, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Homozygous mutations, 2 identical gene versions (alleles), 1 from each biological parent, are exceptional. Clinical descriptions of affected families, comprising few carriers only, are scattered throughout the literature, hindering evidence generation.

Methods

Included in this literature analysis were 5 RET families with ≥1 homozygous carrier and ≥3 heterozygous carriers per family.

Results

In consanguineous families with first-degree cousins, homozygotes presented with node-positive medullary thyroid cancer and pheochromocytoma in their mid-teens, whereas heterozygotes presented in their end-30s and early 40s. Homozygotes developed node-positive medullary thyroid cancer 27.4 years and pheochromocytoma 23 years earlier than heterozygotes. These age differences were smaller in the 15 families carrying founder mutation p.Leu666delinsAsnSer, whereas homozygotes developed node-positive medullary thyroid cancer in their mid-40s, 6 years earlier than heterozygotes in their early 50s.

Conclusion

These results, limited in scope and size and modulated by extent of consanguinity, are consistent with moderate dose–response effects accelerating MEN2A development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Endocrine Neoplasia Type 2aPheochromocytomaThyroid NeoplasmsAdrenal Gland NeoplasmsCarcinoma, NeuroendocrineAdolescentHumansChildHomozygoteConsanguinityPhenotypeProto-Oncogene Proteins c-retPedigree

Stichwörter der Autor:innen

RET homozygositygenotype–phenotype correlationmedullary thyroid carcinomamultiple endocrine neoplasia type 2pheochromocytoma

Substanzen

Proto-Oncogene Proteins c-retRET protein, human

Autor:innen und Institutionen

  • Medical Faculty, Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, D-06097 Halle (Saale), Germany.
  • Department of General, Visceral and Transplantation Surgery, Division of Endocrine Surgery, University of Duisburg-Essen, D-45122 Essen, Germany.

ORCID-Profile: Andreas Machens

Zitieren

APA

Machens, A., & Dralle, H. (2024). Accelerated MEN2A in homozygous RET carriers in the context of consanguinity. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae025

Vancouver

Machens A, Dralle H. Accelerated MEN2A in homozygous RET carriers in the context of consanguinity. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae025

BibTeX
@article{Machens2024,
  author = {Machens, Andreas and Dralle, Henning},
  title = {Accelerated MEN2A in homozygous RET carriers in the context of consanguinity},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae025}
}
Kostenlos starten →